CHICAGO, ILLINOIS--(Marketwire - January 29, 2008) - MonoGen, Inc., (“Corporation”) (TSX: MOG) today announced that the findings of its pivotal clinical trial of MonoPrep® have been published in the February 2008 issue of the peer-reviewed American Journal of Clinical Pathology.
